Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoClin Corp (OTC Pink - Limited Information:IMCL)

0.12
Delayed Data
As of Jun 13
 0.00 / 0.00%
Today’s Change
0.08
Today|||52-Week Range
2.90
-60.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.5M

Company Description

Immunoclin Corp. provides immunological research, testing and consulting services. The company was founded on February 8, 2011 and is headquartered in Washington, DC.

Contact Information

Immunoclin Corp.
1420 North Street
Washington District Of Columbia 20005
P:(202) 838-8141
Investor Relations:

Employees

Shareholders

Individual stakeholders93.65%
Mutual fund holders--
Other institutional--

Top Executives

Dorothy H. BrayPresident, Chief Executive Officer & Director
Chad S. JohnsonCOO, Secretary, Director & General Counsel
James Scott MunroCFO, Treasurer & Principal Accounting Officer
Khadija BenlhassanDirector & Chief Scientific Officer